Ultrasound-guided botulinum toxin injections for treatment of drooling.

[1]  B. Bloem,et al.  Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections. , 2007, Parkinsonism & related disorders.

[2]  L. B. Aytés,et al.  Salivary gland application of botulinum toxin for the treatment of sialorrhea , 2007 .

[3]  L. Molloy.  Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence , 2007, Current opinion in neurology.

[4]  A. Bentivoglio,et al.  Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. , 2007, Parkinsonism & related disorders.

[5]  G. Szalai,et al.  Ultrasound-guided, intraglandular injection of botulinum toxin A in children suffering from excessive salivation , 2007, The Journal of Laryngology & Otology.

[6]  A. Melo,et al.  Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease? , 2007, Journal of the Neurological Sciences.

[7]  Yung-Yee Chang,et al.  Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea. , 2006, Acta neurologica Taiwanica.

[8]  A. Verma,et al.  Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis , 2006, Muscle & nerve.

[9]  J. Jankovic,et al.  Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms. , 2005, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[10]  F. Gabreëls,et al.  Botulinum toxin effect on salivary flow rate in children with cerebral palsy , 2004, Neurology.

[11]  R. Laskawi,et al.  Reduction of Salivary Flow With Botulinum Toxin: Extended Report on 33 Patients with Drooling, Salivary Fistulas, and Sialadenitis , 2004, The Laryngoscope.

[12]  E. Elovic,et al.  Intraparotid Injection of Botulinum Toxin A as a Treatment to Control Sialorrhea in Children with Cerebral Palsy , 2004, American journal of physical medicine & rehabilitation.

[13]  O. Doğu,et al.  Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease , 2004, Clinical Neurology and Neurosurgery.

[14]  W. Ondo,et al.  A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease , 2004, Neurology.

[15]  A. Kupsch,et al.  A randomized trial of botulinum toxin A for treatment of drooling , 2003, Neurology.

[16]  M. Ellies.  Tierexperimentelle und klinische Untersuchungen zur Sekretionshemmung der Kopfspeicheldrüsen durch Botulinum Toxin A , 2003 .

[17]  J. Perlmutter,et al.  Botulinum toxin B reduces sialorrhea in parkinsonism , 2003, Movement disorders : official journal of the Movement Disorder Society.

[18]  G. Nappi,et al.  Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism , 2003, Movement disorders : official journal of the Movement Disorder Society.

[19]  J. Rotteveel,et al.  The Treatment of Drooling by Ultrasound‐Guided Intraglandular Injections of Botulinum Toxin Type A Into the Salivary Glands , 2003, The Laryngoscope.

[20]  D. Ranoux,et al.  Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia , 2002, Journal of neurology, neurosurgery, and psychiatry.

[21]  D. Suskind,et al.  Clinical Study of Botulinum‐A Toxin in the Treatment of Sialorrhea in Children With Cerebral Palsy , 2002, The Laryngoscope.

[22]  K Turner,et al.  Drooling in Parkinson's disease: a novel speech and language therapy intervention. , 2001, International journal of language & communication disorders.

[23]  M. Porta,et al.  Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders , 2001, Journal of neurology, neurosurgery, and psychiatry.

[24]  M. Naumann,et al.  Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[25]  D. Calne,et al.  Botulinum toxin A as treatment for drooling saliva in PD , 2000, Neurology.

[26]  W. Jost.  Treatment of drooling in Parkinson's disease with botulinum toxin , 1999, Movement disorders : official journal of the Movement Disorder Society.

[27]  K. Bushara.  Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands. , 1997, Medical hypotheses.

[28]  J. Meningaud,et al.  Drooling of saliva: a review of the etiology and management options. , 2006, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[29]  Neil G Hockstein,et al.  Sialorrhea: a management challenge. , 2004, American family physician.

[30]  A. Friedman,et al.  Botulinum toxin for treatment of parkinsonian sialorrhea. , 2001, Neurologia i neurochirurgia polska.

[31]  D. Ryglewicz,et al.  [Atherosclerotic changes in the aorta of patients with ischemic and hemorrhagic stroke]. , 2001, Neurologia i neurochirurgia polska.